使用Player FM应用程序离线!
Expanding HER2 horizons: Implications for NSCLC and beyond
Manage episode 440517874 series 3389426
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC.
The experts
- Dr Razelle Kurzrock - Medical Oncologist, Medical College of Wisconsin, Milwaukee, WI, USA
- Dr Lyudmila Bazhenova - Medical Oncologist, UC San Diego Moores Cancer Center, San Diego, CA, USA
- Dr Ignacio Wistuba - Pathologist, MD Anderson Cancer Center, Houston, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/her2_in_solid_tumours_and_nsclc/
102集单集
Manage episode 440517874 series 3389426
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC.
The experts
- Dr Razelle Kurzrock - Medical Oncologist, Medical College of Wisconsin, Milwaukee, WI, USA
- Dr Lyudmila Bazhenova - Medical Oncologist, UC San Diego Moores Cancer Center, San Diego, CA, USA
- Dr Ignacio Wistuba - Pathologist, MD Anderson Cancer Center, Houston, TX, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/her2_in_solid_tumours_and_nsclc/
102集单集
Alle episoder
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。